B. Barna

B. Barna, L. Calabrese, M. Hamid, 1988, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

Exposure to a Mycobacterial Antigen, ESAT-6, Exacerbates Granulomatous and Fibrotic Changes in a Multiwall Carbon Nanotube Model of Chronic Pulmonary Disease.

B. Barna, M. Thomassen, C. Wingard, 2015, Journal of nanomedicine & nanotechnology.

Studies in a Murine Granuloma Model of Instilled Carbon Nanotubes: Relevance to Sarcoidosis

B. Barna, M. Thomassen, A. Malur, 2021, International journal of molecular sciences.

Elevated IL-10 Inhibits GM-CSF Synthesis in Pulmonary Alveolar Proteinosis

B. Barna, M. Kavuru, T. Bonfield, 2003, Autoimmunity.

Antisense telomerase treatment: induction of two distinct pathways, apoptosis and differentiation

G. Barnett, Y. Kondo, S. Kondo, 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Targeted PPARγ deficiency in alveolar macrophages disrupts surfactant catabolism

B. Barna, Shobha Ghosh, M. Kavuru, 2010, Journal of Lipid Research.

Targeted PPAR³ Deficiency In Alveolar Macrophages Disrupts Surfactant Catabolism

B. Barna, Shobha Ghosh, M. Kavuru, 2010, ATS 2010.

Novel murine model of chronic granulomatous lung inflammation elicited by carbon nanotubes.

A. Rao, B. Barna, R. Podila, 2011, American journal of respiratory cell and molecular biology.

Autoimmune Reactivity in Meniere'S Disease: A Preliminary Report

B. Barna, L. Calabrese, S. E. Kinney, 1983, The Laryngoscope.

Sarcoidosis activates diverse transcriptional programs in bronchoalveolar lavage cells

S. Gharib, B. Barna, M. Kavuru, 2016, Respiratory Research.

Treatment of malignant glioma cells with the transfer of constitutively active caspase-6 using the human telomerase catalytic subunit (human telomerase reverse transcriptase) gene promoter.

S. Srinivasula, E. Alnemri, J. Shay, 2001, Cancer research.

Interleukin-13 sensitivity and receptor phenotypes of human glial cell lines: non-neoplastic glia and low-grade astrocytoma differ from malignant glioma

G. Barnett, R. Prayson, B. Barna, 2000, Cancer Immunology, Immunotherapy.

Alveolar Macrophage Cathelicidin Deficiency in Severe Sarcoidosis

B. Barna, M. Kavuru, M. Thomassen, 2012, Journal of Innate Immunity.

A novel 1,25-dihydroxyvitamin D–activin A pathway in human alveolar macrophages is dysfunctional in patients with pulmonary alveolar proteinosis (PAP)

B. Barna, M. Kavuru, M. Thomassen, 2009, Autoimmunity.

Combination therapy with a synthetic peptide of C-reactive protein and interleukin 2: augmented survival and eradication of pulmonary metastases

S. Medendorp, B. Barna, R. Tubbs, 2005, Cancer Immunology, Immunotherapy.

PPAR-gamma pathways attenuate pulmonary granuloma formation in a carbon nanotube induced murine model of sarcoidosis.

B. Barna, D. Tokarz, M. Thomassen, 2018, Biochemical and biophysical research communications.

Interferon-β impairs induction of HLA-DR antigen expression in cultured adult human astrocytes

R. Ransohoff, B. Barna, B. Jacobs, 1989, Journal of Neuroimmunology.

WAF1/CIP1 increases the susceptibility of p53 non-functional malignant glioma cells to cisplatin-induced apoptosis.

G. Casey, G. Barnett, J. Peterson, 1996, Oncogene.

PPARgamma regulates the expression of cholesterol metabolism genes in alveolar macrophages.

B. Barna, M. Kavuru, M. Thomassen, 2010, Biochemical and biophysical research communications.

ABCG1 is deficient in alveolar macrophages of GM-CSF knockout mice and patients with pulmonary alveolar proteinosis Published, JLR Papers in Press, September 11, 2007.

B. Barna, C. Farver, M. Febbraio, 2007, Journal of Lipid Research.

Macrophage activation and generation of tumoricidal activity by liposome-associated human C-reactive protein.

B. Barna, S. Deodhar, S. Gautam, 1984, Cancer research.

Alveolar Macrophage ABCG1 Deficiency Promotes Pulmonary Granulomatous Inflammation.

K. Gowdy, M. Fessler, B. Barna, 2019, American journal of respiratory cell and molecular biology.

Alveolar macrophage activation in obese patients with obstructive sleep apnea.

B. Barna, W. Pories, M. Kavuru, 2012, Surgery.

Deletion of PPARγ in Alveolar Macrophages Is Associated with a Th-1 Pulmonary Inflammatory Response1

B. Barna, M. Kavuru, M. Thomassen, 2009, The Journal of Immunology.

An inverse relationship between peroxisome proliferator-activated receptor gamma and allergic airway inflammation in an allergen challenge model.

B. Barna, M. Kavuru, T. Bonfield, 2005, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Peroxisome proliferator-activated receptor-gamma is deficient in alveolar macrophages from patients with alveolar proteinosis.

B. Barna, C. Farver, M. Kavuru, 2003, American journal of respiratory cell and molecular biology.

Antagonist effect of insulin-like growth factor I on protein kinase inhibitor-mediated apoptosis in human glioblastoma cells in association with bcl-2 and bcl-xL.

S. Toms, G. Casey, G. Barnett, 1998, Journal of neurosurgery.

Human Alveolar Macrophage Function: Differences Between Smokers and Nonsmokers

B. Barna, H. Wiedemann, M. Ahmad, 1988, Journal of leukocyte biology.

Astrocyte cultures derived from human brain tissue express angiotensinogen mRNA.

R. Ransohoff, B. Barna, A. Milsted, 1990, Proceedings of the National Academy of Sciences of the United States of America.

Interferon-β specifically inhibits interferon-γ-induced class II major histocompatibility complex gene transcription in a human astrocytoma cell line

R. Rudick, R. Ransohoff, E. Frohman, 1991, Journal of Neuroimmunology.

Neutrophil dysfunction. Case studies and review.

B. Barna, M. Clements, J. Clough, 1986, Cleveland Clinic quarterly.

Serological detection of disease activity in SLE.

R. K. Chang, B. Barna, J. Clough, 1992, Clinical biochemistry.

Nitric oxide attenuates beryllium-induced IFNgamma responses in chronic beryllium disease: evidence for mechanisms independent of IL-18.

R. Dweik, B. Barna, C. Farver, 2002, Clinical immunology.

A study of the immunologic aspects of chronic berylliosis.

B. Barna, S. Deodhar, H. S. Van Ordstrand, 1973, Chest.

Suppression of activin A in autoimmune lung disease associated with anti-GM-CSF.

B. Barna, M. Kavuru, T. Bonfield, 2006, Journal of autoimmunity.

Elevated MicroRNA-33 in Sarcoidosis and a Carbon Nanotube Model of Chronic Granulomatous Disease.

M. Fessler, B. Barna, K. Verbanac, 2016, American journal of respiratory cell and molecular biology.

Carbon Nanotube-Induced Pulmonary Granulomatous Disease: Twist1 and Alveolar Macrophage M1 Activation

B. Barna, M. Kavuru, M. Thomassen, 2013, International journal of molecular sciences.

Rituximab therapy in pulmonary alveolar proteinosis improves alveolar macrophage lipid homeostasis

B. Barna, M. Kavuru, M. Thomassen, 2012, Respiratory Research.

An open-label trial of rituximab therapy in pulmonary alveolar proteinosis

B. Barna, M. Kavuru, M. Thomassen, 2011, European Respiratory Journal.

TITLE: An Open-Label Trial of Rituximab Therapy in Pulmonary Alveolar Proteinosis AUTHORS:

B. Barna, M. Kavuru, M. Thomassen, 2011 .

ABCG1 is deficient in alveolar macrophages of GM-CSF knockout mice and patients with pulmonary alveolar proteinosis Published, JLR Papers in Press, September 11, 2007.

B. Barna, C. Farver, M. Febbraio, 2007, Journal of Lipid Research.

patient-oriented and epidemiological research ABCG 1 is deficient in alveolar macrophages of GM-CSF knockout mice and patients with pulmonary alveolar proteinosis

B. Barna, C. Farver, M. Febbraio, 2007 .

Peroxisome proliferator-activated receptor gamma activity is deficient in alveolar macrophages in pulmonary sarcoidosis.

B. Barna, C. Farver, M. Kavuru, 2004, American journal of respiratory cell and molecular biology.

Induction of cytokine messenger RNA and secretion in alveolar macrophages and blood monocytes from patients with lung cancer receiving granulocyte-macrophage colony-stimulating factor therapy.

B. Barna, H. Wiedemann, M. Ahmad, 1991, Cancer research.

Experimental beryllium-induced lung disease. I. Differences in immunologic responses to beryllium compounds in strains 2 and 13 guinea pigs.

B. Barna, S. Deodhar, S. Gautam, 1984, International archives of allergy and applied immunology.

Human astrocytes proliferate in response to tumor necrosis factor alpha

R. Ransohoff, B. Barna, B. Jacobs, 1990, Journal of Neuroimmunology.

Granulomatous disease associated with pulmonary deposition of titanium.

S. Redline, J. Tomashefski, B. Barna, 1986, British journal of industrial medicine.

Induction of in vitro tumoricidal activity in alveolar macrophages and monocytes from patients with lung cancer.

B. Barna, H. Wiedemann, M. Ahmad, 1988, Cancer research.

Human astrocyte growth regulation: interleukin-4 sensitivity and receptor expression

G. Barnett, B. Barna, P. Zhou, 1995, Journal of Neuroimmunology.

Matrix Metalloproteinase-12 Is Required for Granuloma Progression

S. Gharib, B. Barna, D. Tokarz, 2020, Frontiers in Immunology.

FADD gene therapy for malignant gliomas in vitro and in vivo.

G. Barnett, Y. Kondo, S. Kondo, 1998, Human gene therapy.

Elevated gelatinase activity in pulmonary alveolar proteinosis: role of macrophage‐colony stimulating factor

B. Barna, C. Farver, M. Kavuru, 2006, Journal of leukocyte biology.

Elevated monocyte chemotactic proteins 1, 2, and 3 in pulmonary alveolar proteinosis are associated with chemokine receptor suppression.

B. Barna, M. Kavuru, T. Bonfield, 2005, Clinical immunology.

Inflammatory Pathways in Sarcoidosis.

B. Barna, M. Judson, M. Thomassen, 2021, Advances in experimental medicine and biology.

The role of PPARγ in carbon nanotube-elicited granulomatous lung inflammation

B. Barna, M. Thomassen, C. Wingard, 2013, Respiratory Research.

Surfactant downregulates synthesis of DNA and inflammatory mediators in normal human lung fibroblasts.

B. Barna, H. Wiedemann, M. Thomassen, 1996, The American journal of physiology.

Phase I trial of high-dose bolus interleukin-2 and interferon alfa-2a in patients with metastatic malignancy.

S. Medendorp, J. Finke, B. Barna, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase Ia-Ib trial of an anti-GD3 monoclonal antibody in combination with interferon-alpha in patients with malignant melanoma.

S. Medendorp, B. Barna, R. Bukowski, 1990, Journal of biological response modifiers.

Inhibitory effects of tamoxifen and tumor necrosis factor α on human glioblastoma cells

S. Toms, G. Barnett, B. Barna, 1995, Cancer Immunology, Immunotherapy.

Gene Promoter Catalytic Subunit ( Human Telomerase Reverse Transcriptase ) Constitutively Active Caspase-6 Using the Human Telomerase Treatment of Malignant Glioma Cells with the Transfer of Updated

S. Srinivasula, E. Alnemri, J. Shay, 2001 .

Characterization of blood mononuclear and cultured cells in hairy cell leukemia.

R. Savage, B. Barna, J. Mcmahon, 1983, American journal of clinical pathology.

Involvement of interleukin‐1β‐converting enzyme in apoptosis of bFGF‐deprived murine aortic endothelial cells

G. Barnett, J. Peterson, D. Yin, 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Interleukin-4 down-regulates adult human astrocyte DNA synthesis and proliferation.

B. Barna, B. Jacobs, M. Estes, 1993, The American journal of pathology.

In vivo expression of the interleukin 4 receptor alpha by astrocytes in epilepsy cerebral cortex.

G. Barnett, R. Prayson, B. Barna, 2000, Cytokine.

Inhibition of telomerase increases the susceptibility of human malignant glioblastoma cells to cisplatin-induced apoptosis

Yoshikazu Tanaka, Y. Kondo, S. Kondo, 1998, Oncogene.

Modulation of proliferation and antigen expression of a cloned human glioblastoma by interleukin-4 alone and in combination with tumor necrosis factor-α and/or interferon-γ

B. Barna, M. Estes, L. Rogers, 1993 .

Effect of recombinant tumor necrosis factor-alpha on three-dimensional growth, morphology, and invasiveness of human glioblastoma cells in vitro.

G. Barnett, B. Barna, M. Estes, 1993, Journal of neurosurgery.

Divergent responses of human astrocytoma and non-neoplastic astrocytes to tumor necrosis factor alpha involve the 55 kDa tumor necrosis factor receptor

G. Barnett, B. Barna, B. Jacobs, 1993, Journal of Neuroimmunology.

Enhanced DNA synthesis of human glial cells exposed to human leukocyte products

J. Hahn, R. Ransohoff, B. Barna, 1985, Journal of Neuroimmunology.

Monocytes in cystic fibrosis: Responsiveness to microbial stimuli

R. Stern, B. Barna, C. Doershuk, 1990, Pediatric pulmonology.

PPARγ Deficiency Exacerbates Fibrotic Response to Mycobacteria Peptide in Murine Sarcoidosis Model.

B. Barna, B. Muller-Borer, R. Barrington, 2019, American journal of respiratory cell and molecular biology.

Peroxisome Proliferator–activated Receptor-g Deficiency Exacerbates Fibrotic Response to Mycobacteria Peptide in Murine Sarcoidosis Model

B. Barna, B. Muller-Borer, R. Barrington, 2019 .

The M2a Macrophage Phenotype Accompanies Pulmonary Granuloma Resolution in Mmp12 Knock-Out Mice Instilled with Multiwall Carbon Nanotubes

B. Barna, M. Thomassen, A. Mohan, 2021, International journal of molecular sciences.

Differential effect of recombinant granulocyte macrophage colony-stimulating factor on human monocytes and alveolar macrophages.

B. Barna, H. Wiedemann, M. Ahmad, 1989, Cancer research.

Activation of human monocyte tumoricidal activity by C-reactive protein.

B. Barna, S. Deodhar, K. James, 1987, Cancer research.

Immunologic studies of experimental beryllium lung disease in the guinea pig.

B. Barna, S. Deodhar, T. Chiang, 1981, Clinical immunology and immunopathology.

The effects of anabolic steroids and strength training on the human immune response.

D. Kirkendall, B. Barna, R. Lahita, 1989, Medicine and science in sports and exercise.

Immunologic changes in renal cell carcinoma patients receiving gamma interferon.

B. Barna, R. Bukowski, M. Thomassen, 1991, Oncology.

Retroviral Transfer of CPP32β Gene into Malignant Gliomas in Vitro and in Vivo

E. Alnemri, G. Barnett, Yoshikazu Tanaka, 1998 .

Microcytotoxicity and serum blocking factors in malignant melanoma and halo nevus.

B. Barna, H. Roenigk, J. Krebs, 1975, Archives of dermatology.

Practical versus theoretical management of autoimmune inner ear disease

B. Barna, L. Calabrese, S. E. Kinney, 1984, The Laryngoscope.

Nonspecific lymphocyte cytotoxicity in patients with malignant melanoma, renal cell carcinoma, and sarcomas, and in nontumor patients

B. Barna, R. Bukowski, S. Deodhar, 1976, Cancer.

In vitro assessment of cell-mediated immunity in patients with renal cell carcinoma.

J. Montie, B. Barna, S. Deodhar, 1976, The Journal of urology.

Lymphocyte transformation and radioallergosorbent tests in drug hypersensitivity.

B. Barna, S. Deodhar, P. Gogate, 1980, American journal of clinical pathology.

Endophthalmitis associated with sequestered intraocular Propionibacterium acnes.

Z. Zakov, A. Zachary, B. Barna, 1987, American journal of ophthalmology.

Halo nevus: competent surveillance of potential melanoma?

B. Barna, H. Roenigk, J. Krebs, 1977, Cleveland Clinic quarterly.

The therapy of malignant melanoma with transfer factor. A preliminary report.

B. Barna, S. Deodhar, J. Hewlett, 1974, Cleveland Clinic quarterly.

The activity of regional nodes in the evolution of immune responses to allogeneic and isogeneic tumors.

B. Barna, S. Deodhar, 1975, Cancer research.

Analysis of leukocyte adherence to measles‐infected cells in multiple sclerosis

B. Barna, S. Deodhar, J. Conomy, 1981, Annals of neurology.

Activation of human monocytes and alveolar macrophages by a synthetic peptide of C-reactive protein.

B. Barna, H. Wiedemann, M. Thomassen, 1993, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

Carbon Nanotubes and Chronic Granulomatous Disease

B. Barna, M. Judson, M. Thomassen, 2014, Nanomaterials.

Caspase-8 gene therapy using the human telomerase reverse transcriptase promoter for malignant glioma cells.

I. Germano, S. Kyo, M. Takakura, 2002, Human gene therapy.

2-5A antisense telomerase RNA therapy for intracranial malignant gliomas.

Y. Kondo, S. Kondo, B. Barna, 2000, Cancer research.

Immunology, tumor markers, and breast cancer.

B. Barna, S. Deodhar, 1978, The Surgical clinics of North America.

Therapeutic effects of a synthetic peptide of C-reactive protein in pre-clinical tumor models

S. Medendorp, B. Barna, M. Thomassen, 2005, Cancer Immunology, Immunotherapy.

Activation of alveolar macrophage TNF and MCP‐1 expression in vivo by a synthetic peptide of C‐reactive protein

B. Barna, P. Zhou, M. Thomassen, 1996, Journal of leukocyte biology.

Transcriptional survey of alveolar macrophages in a murine model of chronic granulomatous inflammation reveals common themes with human sarcoidosis.

S. Gharib, B. Barna, L. Schnapp, 2018, American journal of physiology. Lung cellular and molecular physiology.

A Antisense Telomerase RNA Therapy for Intracranial Malignant Gliomas 1

Y. Kondo, S. Kondo, B. Barna, 2000 .

Anti-sense oligonucleotide of p21(waf1/cip1) prevents Interleukin 4-mediated elevation of p27(kip1) in low grade astrocytoma cells

G. Barnett, R. Prayson, S. Kondo, 2000, Oncogene.

A lymphocytotoxic factor(s) in plasma of patients with minimal change nephrotic syndrome: partial characterization.

B. Barna, R. Kallen, S. Deodhar, 1983, Clinical immunology and immunopathology.

Experimental beryllium-induced lung disease. II. Analyses of bronchial lavage cells in strains 2 and 13 guinea pigs.

B. Barna, J. Mcmahon, S. Deodhar, 1984, International archives of allergy and applied immunology.

Regulation of monocyte chemoattractant protein-1 expression in adult human non-neoplastic astrocytes is sensitive to tumor necrosis factor (TNF) or antibody to the 55-kDa TNF receptor

G. Barnett, B. Barna, P. Zhou, 1994, Journal of Neuroimmunology.

Autoimmunity in otology.

B. Barna, L. Calabrese, S. E. Kinney, 1986, The American journal of otology.

Autoimmune reactivity in Cogan's syndrome: A preliminary report

B. Barna, R. Tomsak, L. Calabrese, 1983, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

Monocytes in active multiple sclerosis: intact regulation of HLA-DR density in vitro despite decreased HLA-DR density in vivo

R. Rudick, R. Ransohoff, V. Tuohy, 1992, Journal of Neuroimmunology.

Retroviral transfer of CPP32beta gene into malignant gliomas in vitro and in vivo.

E. Alnemri, G. Barnett, Y. Kondo, 1998, Cancer research.

The CDK inhibitor, p27Kip1, is required for IL-4 regulation of astrocyte proliferation.

G. Barnett, S. Kondo, T. Haqqi, 1997, Journal of immunology.

Autoimmune inner ear disease--a real entity?

B. Barna, G. Hughes, 1997, Clinics in laboratory medicine.

Thyroid hormone depletion inhibits astrocytoma proliferation via a p53-independent induction of p21 (WAF1/CIP1).

S. Toms, G. Casey, G. Barnett, 1998, Anticancer research.

Autoimmunity and otologic disease: clinical and experimental aspects.

B. Barna, G. Hughes, 1988, Clinics in laboratory medicine.

Phase I Clinical Trial of Interleukin 2 and α-Interferon: Toxicity and Immunologic Effects

S. Medendorp, J. Finke, S. Murthy, 1989 .

Predictive value of laboratory tests in “autoimmune” inner ear disease: preliminary report

B. Barna, L. Calabrese, S. E. Kinney, 1986, The Laryngoscope.

Clinical diagnosis of immune inner‐ear disease

B. Barna, L. Calabrese, S. E. Kinney, 1988, The Laryngoscope.

Tumor-enhancing effects of cimetidine.

B. Barna, M. Edinger, T. Chiang, 1983, Oncology.

Can Sensitized Lymphocytes Retain Reactivity to Inner Ear Antigens After Retrieval From Frozen Storage?

B. Barna, R. Fairchild, G. Hughes, 1997, The Laryngoscope.

Phase I trial of natural human interferon beta in metastatic malignancy.

S. Medendorp, B. Barna, R. Bukowski, 1991, Cancer research.

Immunological activity of regional lymph nodes in tumor-bearing mice.

B. Barna, S. Deodhar, 1979, Cancer research.

Combination Therapy of Renal Cell Carcinoma with Interleukin-2 and Interferon Alpha: The Cleveland Clinic Experience

S. Medendorp, J. Finke, S. Murthy, 1991 .

Expression of basement membrane and endothelial cell adhesion molecules in vascular malformations of the brain: preliminary observations and working hypothesis.

I. Awad, B. Barna, P. Zhou, 1995, Neurological research.

Laboratory diagnosis of immune inner ear disease.

B. Barna, R. Moscicki, G. Hughes, 1994, The American journal of otology.

Phase I clinical trial of interleukin 2 and alpha-interferon: toxicity and immunologic effects.

S. Medendorp, J. Finke, B. Barna, 1989, Cancer research.

Vascular nodules and plaques resembling chronic mucocutaneous candidiasis in a patient with a low interleukin 2 level.

B. Barna, W. Bergfeld, L. Calabrese, 1993, Journal of the American Academy of Dermatology.

Clinical Application of Beryllium Lymphocyte Proliferation Testing

Barbara P Barna, Daniel A Culver, Belinda Yen-Lieberman, 2003, Clinical Diagnostic Laboratory Immunology.

Phase I Clinical Trial of Interleukin 2 and a-Interferon: Toxicity and Immunologie Effects1

S. Medendorp, B. Barna, R. Bukowski, 2006 .

Rituximab Depletes B-Lymphocytes and Improves Symptoms in Pulmonary Alveolar Proteinosis

B. Barna, M. Kavuru, M. Thomassen, 2008 .

Alveolar macrophages of GM-CSF knockout mice exhibit mixed M1 and M2 phenotypes

B. Barna, M. Kavuru, M. Thomassen, 2013, BMC Immunology.

Human monocytes produce monocyte chemoattractant protein 1 (MCP-1) in response to a synthetic peptide derived from C-reactive protein.

B. Barna, P. Zhou, M. Thomassen, 1995, Clinical immunology and immunopathology.

Immune mechanisms in beryllium lung disease.

B. Barna, S. Deodhar, 1991, Cleveland Clinic journal of medicine.

Multiple Sclerosis: Neuroimmunologic Puzzle

B. Barna, 1986, Clinics in Laboratory Medicine.

Serum interleukin 2 and soluble interleukin 2 receptor in patients with multiple sclerosis who are experiencing severe fatigue.

R. Rudick, B. Barna, 1990, Archives of neurology.

PPARγ Deficiency in Carbon Nanotube-elicited Granulomatous Inflammation Promotes a Th17 Response to a Microbial Antigen

B. Barna, R. Barrington, M. Thomassen, 2020, Journal of nanomedicine & nanotechnology.

Depressed peroxisome proliferator-activated receptor gamma (PPargamma) is indicative of severe pulmonary sarcoidosis: possible involvement of interferon gamma (IFN-gamma).

B. Barna, J. Drazba, C. Farver, 2006, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.

Immune Reactivity in Bell's Palsy

B. Barna, H. Tucker, L. Calabrese, 1986, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

Multiplexed Particle-Based Anti-Granulocyte Macrophage Colony Stimulating Factor Assay Used as Pulmonary Diagnostic Test

B. Barna, M. Kavuru, T. Bonfield, 2005, Clinical Diagnostic Laboratory Immunology.

Inhibition of lung metastases in mice bearing a malignant fibrosarcoma by treatment with liposomes containing human C-reactive protein.

B. Barna, S. Deodhar, K. James, 1982, Cancer research.

Interferon-beta specifically inhibits interferon-gamma-induced class II major histocompatibility complex gene transcription in a human astrocytoma cell line.

R. Rudick, R. Ransohoff, E. Frohman, 1991, Journal of Neuroimmunology.

Regulation of monocyte chemoattractant protein-1 expression in adult human non-neoplastic astrocytes is sensitive to tumor necrosis factor (TNF) or antibody to the 55-kDa TNF receptor

G. Barnett, B. Barna, P. Zhou, 1994, Journal of Neuroimmunology.

Modulation of human alveolar macrophage tumoricidal activity by C-reactive protein.

B. Barna, H. Wiedemann, M. Ahmad, 1988, Journal of biological response modifiers.

Monocyte interactions with solid substrates monitored by chemiluminescence.

B. Barna, P. Parks, S. Deodhar, 1982, Biomaterials, medical devices, and artificial organs.